Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide

Medical and Pediatric Oncology

Volumn 35, Issue 6, 2000, Pages 597-602

  Reynolds, C P ^a,b   Wang, Y ^a,b   Melton, L J ^a   Einhorn, P A ^a   Slamon, D J ^c   Maurer, B J ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

c myc; Fenretinide; MYCN; Neuroblastoma; Retinoic acid

Indexed keywords

CYTOTOXIC AGENT; FENRETINIDE; ISOTRETINOIN;

CANCER RESISTANCE; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; ONCOGENE MYC; PRIORITY JOURNAL; TUMOR RESISTANCE;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; FENRETINIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; NEUROBLASTOMA; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0033646876     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20001201)35:6<597::AID-MPO23>3.0.CO;2-B     Document Type: Conference Paper

References (32)

1. Treatment of high risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
2. Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation
3. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation
4. Response of neuroblastoma to retinoic acid in vitro and in vivo
5. Comparison of 13-cis-retinoic acid to trans-retinoic acid using human neuroblastoma cell lines
6. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma
7. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide
8. N-(4-hydroxyphenyl)retinamide: A potent inducer of apoptosis in human neuroblastoma cells
9. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: Apoptosis versus differentiation
10. N-(4-hydroxyphenyl)retinamide increases ceramide and reactive oxygen species and induces mixed apoptosis/necrosis in neuroblastoma cell lines
11. Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines
12. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy
13. Characterization of human neuroblastoma cell lines established before and after therapy
14. Biological classification of cell lines derived from human extra-cranial neural tumors
15. N-myc expression in human neuroblastoma cell lines without N-myc gene amplification
16. Expression of protein gene product 9 5 and tyrosine hydroxylase in childhood small round cell tumors
17. N-myc transduction into human neuroblastoma cells enhances aggressive behavior
18. Retroviral vectors
19. A novel 96-well plate cytotoxicity assay based on fluorescence digital imaging microscopy
20. A fluorescence digital image microscopy system for quantifying relative cell nurnbers in tissue culture plates
21. Application of biotin, digoxigenin or fluorescein conjugated deoxynucleotides to label DNA strand breaks for analysis of cell proliferation and apoptosis using flow cytometry
22. Retinoid therapy of neuroblastoma
23. Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl) retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells
24. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines
25. The effect of tamoxifen and fenretinimide on human colorectal cancer cell lines in vitro
26. Retinoid receptor-dependent and-independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells
27. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid
28. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines
29. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma
30. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression
31. Factors affecting plasma retinol decline during long-term administration of the synthetic retinoid fenretinide in breast cancer patients
32. A phase I pharmacokinetic study of fenretinide (HPR) in children with high-risk solid tumors